ADD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.487200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.190400E-01
Normal-vs-Stage2
6.695400E-01
Normal-vs-Stage3
4.593200E-01
Normal-vs-Stage4
4.704000E-01
Stage1-vs-Stage2
7.887600E-01
Stage1-vs-Stage3
8.297600E-01
Stage1-vs-Stage4
1.860810E-01
Stage2-vs-Stage3
6.373400E-01
Stage2-vs-Stage4
3.001200E-01
Stage3-vs-Stage4
2.056600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.763200E-01
Normal-vs-AfricanAmerican
8.281800E-01
Normal-vs-Asian
8.971000E-01
Caucasian-vs-AfricanAmerican
2.320800E-01
Caucasian-vs-Asian
4.799800E-01
AfricanAmerican-vs-Asian
6.569800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.655800E-01
Normal-vs-Female
7.512800E-01
Male-vs-Female
4.236800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.842400E-01
Normal-vs-Age(41-60Yrs)
9.354000E-01
Normal-vs-Age(61-80Yrs)
5.067400E-01
Normal-vs-Age(81-100Yrs)
5.762200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.301400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.757600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.042000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.796100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.674000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.916600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.154800E-01
Normal-vs-Daily Drinker
3.322000E-01
Normal-vs-Weekly Drinker
3.892000E-01
Normal-vs-Occasional Drinker
8.872800E-01
Normal-vs-Social Drinker
4.375400E-01
Non Drinker-vs-Daily Drinker
2.491200E-01
Non Drinker-vs-Weekly Drinker
3.218000E-01
Non Drinker-vs-Occasional Drinker
5.877400E-01
Non Drinker-vs-Social Drinker
4.599000E-01
Daily Drinker-vs-Weekly Drinker
9.858800E-01
Daily Drinker-vs-Occasional Drinker
1.776830E-01
Daily Drinker-vs-Social Drinker
7.996800E-01
Weekly Drinker-vs-Occasional Drinker
2.534400E-01
Weekly Drinker-vs-Social Drinker
8.166200E-01
Occasional Drinker-vs-Social Drinker
3.301200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.853800E-02
Normal-vs-Grade 2
6.424000E-03
Normal-vs-Grade 3
1.137900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.071500E-02
Grade 1-vs-Grade 3
1.382400E-01
Grade 1-vs-Grade 4
9.853800E-02
Grade 2-vs-Grade 3
7.881400E-01
Grade 2-vs-Grade 4
6.424000E-03
Grade 3-vs-Grade 4
1.137900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.347400E-01
Normal-vs-NonDiabetic
5.137000E-01
Diabetic-vs-NonDiabetic
9.698800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.463400E-01
Normal-vs-NoPancreatitis
5.706400E-01
Pancreatitis-vs-NoPancreatitis
5.166400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.675200E-01
Normal-vs-N1
6.816000E-01
N0-vs-N1
7.711000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.043600E-01
Normal-vs-TP53-NonMutant
8.519000E-01
TP53-Mutant-vs-TP53-NonMutant
2.998400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
